Stockscreener 앱 받기
1.43
0.70%
0.01
전일 마감가:
$1.42
열려 있는:
$1.41
하루 거래량:
33,623
Relative Volume:
0.21
시가총액:
$7.84M
수익:
-
순이익/손실:
$-6.91M
주가수익비율:
-0.4387
EPS:
-3.26
순현금흐름:
$-6.14M
1주 성능:
-0.69%
1개월 성능:
-2.05%
6개월 성능:
+2.14%
1년 성능:
-69.44%
1일 변동 폭
$1.38
$1.44
1주일 범위
$1.35
$1.49
52주 변동 폭
$1.15
$4.81
Galmed Pharmaceuticals Ltd Stock (GLMD) Company Profile
GLMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GLMD
Galmed Pharmaceuticals Ltd
|
1.43 | 7.78M | 0 | -6.91M | -6.14M | -3.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.27 | 107.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
474.00 | 64.39B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
579.34 | 61.13B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
834.75 | 52.30B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.31 | 35.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Galmed Pharmaceuticals Ltd Stock (GLMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-05-22 | 다운그레이드 | B. Riley FBR | Buy → Neutral |
| 2020-02-04 | 개시 | Craig Hallum | Buy |
| 2020-01-30 | 재개 | Cantor Fitzgerald | Overweight |
| 2019-12-02 | 개시 | Canaccord Genuity | Buy |
| 2018-12-12 | 개시 | B. Riley FBR | Buy |
| 2018-08-02 | 재확인 | Maxim Group | Buy |
| 2018-07-13 | 개시 | Stifel | Buy |
| 2018-07-12 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-06-12 | 재확인 | H.C. Wainwright | Buy |
| 2018-03-15 | 업그레이드 | Maxim Group | Hold → Buy |
| 2018-02-14 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2018-02-12 | 재확인 | H.C. Wainwright | Buy |
| 2017-11-15 | 개시 | ROTH Capital | Buy |
| 2017-08-08 | 재확인 | H.C. Wainwright | Buy |
| 2017-07-31 | 재확인 | Maxim Group | Buy |
| 2016-08-01 | 재확인 | Maxim Group | Buy |
| 2016-07-06 | 재개 | ROTH Capital | Buy |
| 2016-03-28 | 재개 | H.C. Wainwright | Buy |
| 2015-06-23 | 개시 | H.C. Wainwright | Buy |
| 2015-05-06 | 개시 | Sun Trust Rbsn Humphrey | Buy |
모두보기
Galmed Pharmaceuticals Ltd 주식(GLMD)의 최신 뉴스
How to track smart money flows in Galmed Pharmaceuticals Ltd.Portfolio Update Report & Low Risk Investment Opportunities - newser.com
Is Galmed Pharmaceuticals Ltd. (GPH) stock resilient in recession scenariosWeekly Earnings Recap & Weekly Return Optimization Alerts - newser.com
What Fibonacci levels say about Galmed Pharmaceuticals Ltd. rebound2025 Earnings Impact & Short-Term Trading Opportunity Alerts - newser.com
What institutional flow reveals about Galmed Pharmaceuticals Ltd.Trade Entry Summary & Detailed Earnings Play Strategies - newser.com
Multi factor analysis applied to Galmed Pharmaceuticals Ltd.2025 Technical Overview & Safe Capital Growth Stock Tips - newser.com
What data driven models say about Galmed Pharmaceuticals Ltd.’s futureQuarterly Trade Report & Growth Focused Entry Reports - newser.com
Key metrics from Galmed Pharmaceuticals Ltd.’s quarterly dataJuly 2025 Earnings & Entry and Exit Point Strategies - newser.com
Analyzing drawdowns of Galmed Pharmaceuticals Ltd. with statistical tools2025 Big Picture & Low Risk Entry Point Tips - newser.com
How Galmed Pharmaceuticals Ltd. stock reacts to inflationary pressuresWeekly Trend Summary & Fast Gaining Stock Strategy Reports - newser.com
Will Galmed Pharmaceuticals Ltd. benefit from macro trendsMarket Activity Report & Real-Time Stock Price Movement Reports - newser.com
Why Galmed Pharmaceuticals Ltd. stock remains on buy listsMarket Rally & Advanced Technical Signal Analysis - newser.com
Galmed Pharmaceuticals Ltd.’s volatility index tracking explainedIPO Watch & Target Return Focused Picks - newser.com
News impact scoring models applied to Galmed Pharmaceuticals Ltd.Portfolio Value Summary & Daily Volume Surge Signals - newser.com
Can you recover from losses in Galmed Pharmaceuticals Ltd.2025 Key Highlights & Community Verified Trade Alerts - newser.com
How to monitor Galmed Pharmaceuticals Ltd. with trend dashboardsPortfolio Gains Report & Consistent Income Trade Ideas - newser.com
Is Galmed Pharmaceuticals Ltd. (GPH) stock supported by free cash flow2025 Major Catalysts & High Accuracy Investment Signals - nchmf.gov.vn
How Galmed Pharmaceuticals Ltd. stock reacts to Fed rate cutsGDP Growth & AI Based Trade Execution Alerts - nchmf.gov.vn
Aug EndMonth: Is Galmed Pharmaceuticals Ltd. (GPH) stock supported by free cash flow2025 Major Catalysts & Free Long-Term Investment Growth Plans - Trung tâm Dự báo KTTV quốc gia
Options Flow: Is Galmed Pharmaceuticals Ltd. stock a top momentum playMarket Growth Report & Risk Adjusted Buy and Sell Alerts - nchmf.gov.vn
Published on: 2025-10-18 04:11:48 - nchmf.gov.vn
Galmed Pharmaceuticals Ltd.Ordinary Shares (NQ: GLMD - FinancialContent
Applying Elliott Wave Theory to Galmed Pharmaceuticals Ltd.2025 Momentum Check & Reliable Entry Point Trade Alerts - newser.com
Understanding Galmed Pharmaceuticals Ltd.’s price movementWeekly Loss Report & Weekly Sector Rotation Insights - newser.com
Is Galmed Pharmaceuticals Ltd. a candidate for recovery playJuly 2025 Catalysts & High Accuracy Swing Trade Signals - newser.com
What to do if you’re stuck in Galmed Pharmaceuticals Ltd.July 2025 Sector Moves & Safe Swing Trade Setups - newser.com
Can volume confirm reversal in Galmed Pharmaceuticals Ltd.Portfolio Update Report & Advanced Swing Trade Entry Alerts - newser.com
Galmed Pharmaceuticals Ltd (GLMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.32%
1.34%
자본화:
|
볼륨(24시간):